Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Inflammatory Bowel Diseases

Free Subscription 12.01.2026 1 AJR Am J Roentgenol 1 Aliment Pharmacol Ther 1 Am J Gastroenterol 1 BMC Gastroenterol 8 Dig Dis Sci 1 Dis Colon Rectum 2 Gut 3 Inflamm Bowel Dis 1 J Clin Gastroenterol 1 J Crohns Colitis 2 J Gastroenterol 3 Lancet Gastroenterol Hepatol 1 Mediators Inflamm 1 Minerva Gastroenterol (Torino) 1 Scand J Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. DILLMAN JR, Rieder F, Baker ME, Fletcher JG, et al
   Probable Stricturing in Small Bowel Crohn Disease: In Support of SAR Consensus Recommendations.
   AJR Am J Roentgenol. 2026 Jan 7. doi: 10.2214/AJR.25.34245.
   PubMed         Abstract available
   
   

   
   Aliment Pharmacol Ther

2. KUMAR A, Patil AN, Grewal J, Kumaravel J, et al
   Clinical Trial: Long Versus Short Tapering of Steroids in Steroid Responsive Moderate to Severely Active Ulcerative Colitis-A Randomised Controlled Trial.
   Aliment Pharmacol Ther. 2026 Jan 2. doi: 10.1111/apt.70509.
   PubMed         Abstract available
   
   

   
   Am J Gastroenterol

3. REINISCH W, Atreya R, Rieder F, Jairath V, et al
   Clinical Trial Endpoints for Perianal Fistulizing Crohn's Disease.
   Am J Gastroenterol. 2026 Jan 8. doi: 10.14309/ajg.0000000000003906.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

4. ALKRINAWI J, Alnees M, Masu'd M, Abu Hamdeh N, et al
   Phenotype-specific determinants of health-related quality of life in Crohn's disease and ulcerative colitis: a multicenter cross-sectional study.
   BMC Gastroenterol. 2026 Jan 8. doi: 10.1186/s12876-025-04584.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

5. ALI MP, West RL, Duijvestein M, van der Woude CJ, et al
   Implementation of Outcome-Based Quality Improvement in Dutch Inflammatory Bowel Disease Centres.
   Dig Dis Sci. 2026 Jan 9. doi: 10.1007/s10620-025-09636.
   PubMed         Abstract available
   
   
6. ZHOU P, Zhang K, Pan H, Wang J, et al
   High Complexity Anal Fistula in Perianal Fistula Crohn's Disease with Rectal Fistula.
   Dig Dis Sci. 2026 Jan 9. doi: 10.1007/s10620-025-09664.
   PubMed        
   
   
7. CASTILLO G, Beaty W, Delau O, Sultan K, et al
   Longitudinal Study of Sexual Dysfunction in Men and Women with Inflammatory Bowel Disease Initiating Biologic or Small Molecule Therapy.
   Dig Dis Sci. 2026 Jan 8. doi: 10.1007/s10620-025-09652.
   PubMed         Abstract available
   
   
8. VAN LIEROP LMA, Hoentjen F
   Extending Knowledge: The Case for Treat-to-Target Management in Patients with Ulcerative Colitis Who Fail Early Treatment.
   Dig Dis Sci. 2026 Jan 8. doi: 10.1007/s10620-025-09662.
   PubMed        
   
   
9. GARCIA NM, Memel Z, Zou Y, Thiemann A, et al
   Upadacitinib Is Safe and Effective in Older Adults: A Real-World Experience Comparing Safety and Efficacy in Younger Versus Older Adults with Inflammatory Bowel Disease.
   Dig Dis Sci. 2026 Jan 5. doi: 10.1007/s10620-025-09647.
   PubMed         Abstract available
   
   
10. DEVI J, Jena A, Hassan A, Lohia R, et al
    Response to Correspondence on Global Training in Inflammatory Bowel Disease.
    Dig Dis Sci. 2026 Jan 3. doi: 10.1007/s10620-025-09628.
    PubMed         Abstract available
    
    
11. BARTLETT R, Mohamedrashed M, Yogakanthi S, Chew M, et al
    Trends in Length of Stay, Steroid Use and Colectomy Rates in Patients Admitted with Acute Severe Ulcerative Colitis: The Impact of Accelerated and Intensified Infliximab Dosing.
    Dig Dis Sci. 2026 Jan 3. doi: 10.1007/s10620-025-09635.
    PubMed         Abstract available
    
    
12. CHANG A, Shahrvini B, Oh J, Prajapati DP, et al
    Increased Autoimmunity Burden Is a Risk Factor for Developing Irritable Bowel Syndrome-Like Symptoms in Quiescent Inflammatory Bowel Disease.
    Dig Dis Sci. 2026 Jan 3. doi: 10.1007/s10620-025-09633.
    PubMed         Abstract available
    
    

    
    Dis Colon Rectum

13. HOLUBAR SD, Russell T, Neel N, Hull TL, et al
    Biologics Before Surgery Are Not Associated With Postoperative Complications after Surgery for Inflammatory Bowel Disease: A National Surgery Quality Improvement Program Inflammatory Bowel Disease Collaborative Causal Inference Analysis.
    Dis Colon Rectum. 2026 Jan 6. doi: 10.1097/DCR.0000000000004077.
    PubMed         Abstract available
    
    

    
    Gut

14. MAYORGA L, Noguera Segura A, Campderros L, Pons-Tarin M, et al
    Distinct microbial mediators link diet to inflammation in Crohn's disease and ulcerative colitis.
    Gut. 2026 Jan 6:gutjnl-2025-337480. doi: 10.1136/gutjnl-2025-337480.
    PubMed         Abstract available
    
    
15. ZHANG J, Mak JWY, Ng SC
    Gut microbiome in IBD: past, present and the future.
    Gut. 2026;75:398-410.
    PubMed         Abstract available
    
    

    
    Inflamm Bowel Dis

16. TURNER D, Lomax KG, Veereman G, Griffiths AM, et al
    Efficacy, Safety, and Pharmacokinetics of Golimumab in Children with Moderately-To-Severely Active Ulcerative Colitis: Results from the PURSUIT 2 Study.
    Inflamm Bowel Dis. 2026 Jan 8:izaf322. doi: 10.1093.
    PubMed         Abstract available
    
    
17. ANDERSON SR, Osman A, Zamani M, Alayo Q, et al
    Systematic Review With Meta-Analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2026;32:39-52.
    PubMed         Abstract available
    
    
18. HUANG YJ, Lin JA, Chen WM, Shia BC, et al
    Low-Dose Aspirin and the Prevention of Colorectal Cancer in Inflammatory Bowel Disease: A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2026 Jan 9:izaf304. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Clin Gastroenterol

19. FELDMAN HT, Tejan J, Victoria R, Rupawala A, et al
    Wearable Technology and Remote Physiological Monitoring in Inflammatory Bowel Disease: A Systematic Review.
    J Clin Gastroenterol. 2026 Jan 5. doi: 10.1097/MCG.0000000000002319.
    PubMed         Abstract available
    
    

    
    J Crohns Colitis

20. JONES F, Lavelle A, McCarthy F, Patchett S, et al
    Quality metrics reflecting patient experience of GI endoscopy in Inflammatory Bowel Disease: results of national endoscopy dataset analysis.
    J Crohns Colitis. 2026 Jan 9:jjaf211. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    J Gastroenterol

21. PU T, Feng R, Wang C, Zhao Y, et al
    METTL3/YTHDF1 drives M1 macrophage polarization and aggravates ulcerative colitis progression by regulating m6A modification of SerpinB5 mRNA and FBXO32-dependent NF-kappaB pathway.
    J Gastroenterol. 2026 Jan 4. doi: 10.1007/s00535-025-02341.
    PubMed         Abstract available
    
    
22. NAMBU R, Iwama I, Takeuchi I, Hagiwara SI, et al
    Real-world outcomes of ustekinumab, vedolizumab, and tumor necrosis factor inhibitors in very-early-onset inflammatory bowel disease: a multi-center cohort study.
    J Gastroenterol. 2026 Jan 3. doi: 10.1007/s00535-025-02334.
    PubMed         Abstract available
    
    

    
    Lancet Gastroenterol Hepatol

23. VISSER E, Reijntjes MA, Heuthorst L, Stellingwerf ME, et al
    Appendicectomy versus switching to a JAK inhibitor in inducing remission in patients with active ulcerative colitis after biologic therapy failure (COSTA): 1-year results of a multicentre, prospective, cohort study.
    Lancet Gastroenterol Hepatol. 2026 Jan 6:S2468-1253(25)00291.
    PubMed         Abstract available
    
    
24. TODESCATTO AD, Kotze PG
    Appendicectomy: a disease-modifying treatment for ulcerative colitis?
    Lancet Gastroenterol Hepatol. 2026 Jan 6:S2468-1253(25)00303.
    PubMed        
    
    
25. HONAP S, Jairath V, Magro F, Danese S, et al
    Clinical remission in ulcerative colitis: restoring precision in trial terminology.
    Lancet Gastroenterol Hepatol. 2026;11:96-97.
    PubMed        
    
    

    
    Mediators Inflamm

26. GADZHANOVA S, Roughead E
    Non-Responders to Biologic Disease Modifying Antirheumatic Treatment for Inflammatory Bowel Diseases.
    Mediators Inflamm. 2025;2025:6977602.
    PubMed         Abstract available
    
    

    
    Minerva Gastroenterol (Torino)

27. MURGIANO M, Del Gaudio A, Puca P, Parello S, et al
    Mirikizumab effectiveness in a pregnant woman with acute severe ulcerative colitis: a case report.
    Minerva Gastroenterol (Torino). 2025;71:370-375.
    PubMed         Abstract available
    
    

    
    Scand J Gastroenterol

28. JAHNSEN ME, Detlie TE, Eide GE, Moum B, et al
    High-dose intravenous iron improves quality of life in patients with inflammatory Bowel disease and iron deficiency.
    Scand J Gastroenterol. 2026 Jan 3:1-9. doi: 10.1080/00365521.2025.2608181.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.